Friess, Jörg
Hecker, Michael
Roch, Luisa
Koczan, Dirk
Fitzner, Brit
Angerer, Ines Charlotte
Schröder, Ina
Flechtner, Kristin
Thiesen, Hans-Jürgen
Winkelmann, Alexander
Zettl, Uwe Klaus
Article History
Received: 26 August 2016
Accepted: 4 January 2017
First Online: 3 February 2017
Competing interests
: M.H. received speaking fees and travel funds from Bayer HealthCare, Biogen, Novartis and Teva. A.W. received speaking fees and travel funds from Bayer HealthCare, Genzyme, Merck Serono and Novartis. U.K.Z. received research support as well as speaking fees and travel funds from Almirall, Bayer HealthCare, Biogen, Merck Serono, Novartis, Sanofi and Teva. J.F., L.R., D.K., B.F., I.C.A., I.S., K.F. and H.J.T. declare that they have no competing interests.